Contact Nos.: Customer Images Maria L
95% CI: 0.231, 0.132) or OC (: 0.109
314 Molecular-targeted therapy combined with chemotherapy Cisplatin is the paramount and classical first-line concurrent chemotherapy drug, compared with fluorouracil, oxaliplatin, or nedaplatin
10.1016/j.cmet.2010.09.004 276 TeraiM.LondinE.RochaniA.LinkE.LamB.KaushalG.et al
By modulating oxidative and inflammatory biomarkers, NAC co-treatment significantly reduced the cytotoxic and genotoxic effects of Hg exposure in the lungs
found, in a relatively small Israelian cohort, CagA seropositivity to be strongly associated with an increased risk for not only gastric cancer (OR=88.1), as expected but also for CRC (OR=10.6) (Shmuely et al., 2001)